drugset / Trial / NCT07312773
A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-231A and AD-231B and AD-231C
Non-randomizedParallel-groupOpen-labelTreatment
Summary
To evaluate the pharmacokinetic interactions of AD-231A, AD-231B, and AD-231C in healthy adult volunteers.
Timeline
- Start
- 2026-01-23
- Primary completion
- 2026-02-07
- Completion
- 2026-02-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AD-231A | Unknown | — | Oral |
| Subject | AD-231B | Unknown | — | Oral |
| Subject | AD-231C | Unknown | — | Oral |